Delivery Order SPE2DX22D0010-SPE2D826FAD05

The Defense Logistics Agency's Medical Supply Chain awarded a $14.8K delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 6, 2025, with final completion scheduled for October 7, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania.

AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical federal medical procurement requirements through its extensive portfolio of pharmaceutical products and medical supplies. Under the prime IDC vehicle, the company supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's consistent track record of competitively awarded, non-set-aside contracts demonstrates its capability to meet federal requirements across a broad spectrum of medical products, from routine supplies to specialized pharmaceuticals supporting diverse clinical needs.